Internal Medicine, Hematology · Charlotte, NC
NPI
1629109285
Since 2007
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1021 Morehead Medical Dr, Ste A
Charlotte, NC, 28204
Phone (980) 442-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,704
62 services
Medicare patients, 2024
29
Average age 55
Drug cost, 2024
$872K
815 prescriptions
Company payments, 2025
$3,033
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Payal C Desai was code 99214 (office e&m - established), 25 times for 15 patients. In total Payal C Desai billed 62 services in 9 codes, and Medicare paid $4,704.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 25 | 15 | $55.93 | $1,398 |
| 99215 Office E&M - Established | Facility | 18 | 13 | $103.41 | $1,861 |
By year: 2022 $4,825 for 49 services; 2023 $6,592 for 85 services; 2024 $4,704 for 62 services.
Medicare prescription drug claims, 2024
In 2024, the drug Payal C Desai prescribed most often to Medicare patients was Hydroxyurea, with 131 prescriptions and refills. In total Payal C Desai wrote 815 Medicare prescriptions that cost $872K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 131 | 174 | 39 | $2,904 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 58 | 59 | 17 | $12K |
| Gabapentin Generic | 52 | 64 | 15 | $357 |
| Oxycodone Hcl Generic | 52 | 52 | 19 | $464 |
| Endari Glutamine | 46 | 48 | Under 11 | $166K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 43 | 43 | Under 11 | $691 |
| Xarelto Rivaroxaban | 32 | 32 | Under 11 | $18K |
| Omeprazole Generic | 32 | 38 | Under 11 | $147 |
| Oxbryta Voxelotor | 30 | 33 | 11 | $361K |
| Ibuprofen Generic | 28 | 28 | Under 11 | $125 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 27 | 27 | Under 11 | $494 |
| Deferasirox Generic | 27 | 29 | Under 11 | $6,600 |
| Duloxetine Hcl Generic | 26 | 34 | Under 11 | $209 |
| Mirtazapine Generic | 17 | 17 | Under 11 | $64.18 |
| Ondansetron Hcl Generic | 17 | 17 | Under 11 | $153 |
Brand drugs: 170 claims; generic drugs: 645 claims; opioid claims: 130.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Payal C Desai $3,033 ($3,033 in general payments such as food, travel and fees) from 7 companies. The largest payer was Pfizer Inc. with $1,121.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.